• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

定制血管与治疗性血管再生

Designer blood vessels and therapeutic revascularization.

作者信息

Berglund Joseph D, Galis Zorina S

机构信息

Department of Medicine, Emory University, 1639 Pierce Drive-WMB, Atlanta, GA 30322, USA.

出版信息

Br J Pharmacol. 2003 Oct;140(4):627-36. doi: 10.1038/sj.bjp.0705457.

DOI:10.1038/sj.bjp.0705457
PMID:14534146
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1574062/
Abstract

Inadequate vascular perfusion leads to fatal heart attacks, chronic ulcers, and other serious clinical conditions. The body's capacity to restore vascular perfusion through angiogenesis and arteriogenesis is often impaired by pre-existing disease, and availability of native replacements for nonfunctional arteries is limited in many patients. Thus, recreating blood vessels of various calibres through novel engineering technologies has emerged as a radical option among therapeutic strategies for revascularization. Ranging from artificial, recycled or reassembled natural conduits to sophisticated microdevices, we refer to these as 'designer blood vessels'. Our common efforts to continuously improve vascular replacement design have provided many clues about our own blood vessels, but nature's ability to create nonthrombogenic, immunocompatible, strong, yet biologically responsive blood vessels remains unparalleled. Just as art reproductions never equal the original masterpiece, designer blood vessels may never attain nature's perfection. Nevertheless, they will provide a valuable option as long as they come close enough and are available to many.

摘要

血管灌注不足会导致致命的心脏病发作、慢性溃疡和其他严重的临床病症。机体通过血管生成和动脉生成来恢复血管灌注的能力常常会因既有疾病而受损,而且对于许多患者而言,功能性动脉的天然替代物的可用性有限。因此,通过新型工程技术再造各种管径的血管已成为血管再通治疗策略中的一种激进选择。从人工的、回收利用的或重新组装的天然管道到精密的微型装置,我们将这些称为“定制血管”。我们不断改进血管替代物设计的共同努力为了解我们自身的血管提供了许多线索,但大自然创造出无血栓形成、免疫相容、坚固且具有生物反应性的血管的能力仍然是无与伦比的。正如艺术复制品永远无法等同于原作杰作一样,定制血管可能永远无法达到大自然的完美程度。然而,只要它们足够接近完美并且可供许多人使用,它们就将提供一种有价值的选择。

相似文献

1
Designer blood vessels and therapeutic revascularization.定制血管与治疗性血管再生
Br J Pharmacol. 2003 Oct;140(4):627-36. doi: 10.1038/sj.bjp.0705457.
2
Tissue engineering strategies for in vivo neovascularisation.体内新血管形成的组织工程策略。
Expert Opin Biol Ther. 2002 Dec;2(8):805-18. doi: 10.1517/14712598.2.8.805.
3
[Combination of reconstructive vascular operations with gene-engineering technologies of angiogenesis stimulation: a present-day policy aimed at improving the remote results of treating patients with lower limb chronic ischaemia].重建性血管手术与血管生成刺激基因工程技术的联合应用:旨在改善下肢慢性缺血患者远期治疗效果的当代策略
Angiol Sosud Khir. 2008;14(4):49-53.
4
[Progress in current vascular surgery].[当前血管外科进展]
Khirurgiia (Mosk). 1991 Jan(1):9-16.
5
Vascular tissue engineering and vascularized 3D tissue regeneration.血管组织工程与血管化三维组织再生
Regen Med. 2007 Sep;2(5):831-7. doi: 10.2217/17460751.2.5.831.
6
Endothelial progenitor cells and their potential clinical applications in peripheral arterial disease.内皮祖细胞及其在周围动脉疾病中的潜在临床应用。
Endothelium. 2005 Sep-Dec;12(5-6):243-50. doi: 10.1080/10623320500476617.
7
Angiogenesis of the heart.心脏血管生成
Microsc Res Tech. 2003 Feb 1;60(2):138-58. doi: 10.1002/jemt.10252.
8
Angiogenesis in health and disease: insights into basic mechanisms and therapeutic opportunities.健康与疾病中的血管生成:对基本机制和治疗机会的见解
J Dent Educ. 2002 Aug;66(8):962-75.
9
Thrombin promotes arteriogenesis and hemodynamic recovery in a rabbit hindlimb ischemia model.凝血酶可促进兔后肢缺血模型中的动脉生成和血流动力学恢复。
J Vasc Surg. 2009 Apr;49(4):1000-12. doi: 10.1016/j.jvs.2008.11.004. Epub 2009 Feb 14.
10
The future of vascular surgery.血管外科的未来。
Cardiovasc Surg. 1994 Jun;2(3):329-30.

引用本文的文献

1
Bio-inspired hemocompatible surface modifications for biomedical applications.用于生物医学应用的仿生血液相容性表面修饰
Prog Mater Sci. 2022 Oct;130. doi: 10.1016/j.pmatsci.2022.100997. Epub 2022 Jun 17.
2
Surface Modification with NGF-Loaded Chitosan/Heparin Nanoparticles for Improving Biocompatibility of Cardiovascular Stent.用负载神经生长因子的壳聚糖/肝素纳米颗粒进行表面修饰以改善心血管支架的生物相容性
Stem Cells Int. 2021 Apr 24;2021:9941143. doi: 10.1155/2021/9941143. eCollection 2021.
3
Extracellular matrix-based biomaterials for cardiac regeneration and repair.基于细胞外基质的生物材料用于心脏再生和修复。
Heart Fail Rev. 2021 Sep;26(5):1231-1248. doi: 10.1007/s10741-020-09953-9.
4
An in vivo study on endothelialized vascular grafts produced by autologous biotubes and adipose stem cells (ADSCs).自体生物管和脂肪干细胞(ADSCs)构建的内皮化血管移植物的体内研究。
J Mater Sci Mater Med. 2017 Sep 15;28(10):166. doi: 10.1007/s10856-017-5986-4.
5
Radiological assessment of bioengineered bone in a muscle flap for the reconstruction of critical-size mandibular defect.用于重建临界大小下颌骨缺损的肌皮瓣中生物工程骨的放射学评估。
PLoS One. 2014 Sep 16;9(9):e107403. doi: 10.1371/journal.pone.0107403. eCollection 2014.
6
Small-diameter vascular tissue engineering.小口径血管组织工程。
Nat Rev Cardiol. 2013 Jul;10(7):410-21. doi: 10.1038/nrcardio.2013.77. Epub 2013 May 21.
7
Strategies and techniques to enhance the in situ endothelialization of small-diameter biodegradable polymeric vascular grafts.增强小直径可生物降解聚合物血管移植物原位内皮化的策略和技术。
Tissue Eng Part B Rev. 2013 Aug;19(4):292-307. doi: 10.1089/ten.TEB.2012.0577. Epub 2013 Feb 13.
8
Redox-dependent mechanisms in coronary collateral growth: the "redox window" hypothesis.氧化还原依赖机制在冠状动脉侧支生长中的作用:“氧化还原窗口”假说。
Antioxid Redox Signal. 2009 Aug;11(8):1961-74. doi: 10.1089/ars.2009.2476.
9
Phthalimide neovascular factor 1 (PNF1) modulates MT1-MMP activity in human microvascular endothelial cells.邻苯二甲酰亚胺新生血管因子1(PNF1)调节人微血管内皮细胞中的MT1-MMP活性。
Biotechnol Bioeng. 2009 Jul 1;103(4):796-807. doi: 10.1002/bit.22310.
10
Expansion of microvascular networks in vivo by phthalimide neovascular factor 1 (PNF1).邻苯二甲酰亚胺新生血管因子1(PNF1)在体内对微血管网络的扩张作用。
Biomaterials. 2008 Dec;29(35):4698-708. doi: 10.1016/j.biomaterials.2008.08.029. Epub 2008 Sep 18.

本文引用的文献

1
Factors regulating arteriogenesis.调节动脉生成的因素。
Arterioscler Thromb Vasc Biol. 2003 Jul 1;23(7):1143-51. doi: 10.1161/01.ATV.0000069625.11230.96. Epub 2003 Apr 3.
2
Microfabricated drug delivery systems: from particles to pores.微纳加工药物递送系统:从颗粒到孔隙
Adv Drug Deliv Rev. 2003 Feb 24;55(3):315-28. doi: 10.1016/s0169-409x(02)00227-2.
3
Circulating endothelial progenitor cells, vascular function, and cardiovascular risk.循环内皮祖细胞、血管功能与心血管风险。
N Engl J Med. 2003 Feb 13;348(7):593-600. doi: 10.1056/NEJMoa022287.
4
Effects of locally applied vascular endothelial growth factor (VEGF) and VEGF-inhibitor to the rabbit tibia during distraction osteogenesis.局部应用血管内皮生长因子(VEGF)和VEGF抑制剂对兔胫骨牵张成骨的影响。
J Orthop Res. 2003 Mar;21(2):335-40. doi: 10.1016/S0736-0266(02)00159-6.
5
A biological hybrid model for collagen-based tissue engineered vascular constructs.一种用于基于胶原蛋白的组织工程血管构建体的生物杂交模型。
Biomaterials. 2003 Mar;24(7):1241-54. doi: 10.1016/s0142-9612(02)00506-9.
6
Tissue engineering skeletal muscle for orthopaedic applications.用于骨科应用的组织工程骨骼肌。
Clin Orthop Relat Res. 2002 Oct(403 Suppl):S228-42. doi: 10.1097/00003086-200210001-00027.
7
Bio-smart hydrogels: co-joined molecular recognition and signal transduction in biosensor fabrication and drug delivery.生物智能水凝胶:生物传感器制造与药物递送中的联合分子识别与信号转导
Biosens Bioelectron. 2002 Dec;17(11-12):973-81. doi: 10.1016/s0956-5663(02)00089-1.
8
Evaluation of platelet and coagulation function in different animal species using the xylum clot signature analyzer.使用木质部凝血特征分析仪评估不同动物物种的血小板和凝血功能。
ASAIO J. 2002 Jul-Aug;48(4):360-4. doi: 10.1097/00002480-200207000-00006.
9
Endovascular treatment of thoracic aortic aneurysms: a review.胸主动脉瘤的血管内治疗:综述
Eur Radiol. 2002 Jun;12(6):1370-87. doi: 10.1007/s00330-001-1277-y. Epub 2002 Mar 20.
10
CD28 function: a balance of costimulatory and regulatory signals.CD28的功能:共刺激信号与调节信号的平衡
J Clin Immunol. 2002 Jan;22(1):1-7. doi: 10.1023/a:1014256417651.